The stock's fall snapped a three-day winning streak.

Zoetis Inc. closed 21.60% short of its 52-week high of $200.33, which the company reached on September 19th.

Phibro Animal Health gains JPMorgan upgrade as analyst forecasts continued growth across key livestock products and long-term ...

The two healthcare companies below generally deliver excellent returns and dividend growth. Consider the following two ...

Each stock has a return on invested capital between 17% and 27%, showing a strong ability to reinvest in their businesses ...

dvm360 connects veterinarians to essential medical news, veterinary expertise, and insights on pet care products and ...

1. Zoetis Zoetis is a leading animal health company with a diverse portfolio of products spanning various categories, including livestock, companion animals, and more.

1. Zoetis Zoetis (ZTS -1.40%) is the top dog in the animal healthcare industry and has outpaced the S&P 500 since its initial public offering (IPO) in 2013.

Fundsmith Equity Fund fell 1.9% in the first six months of the year, two percentage points less than what is perhaps the most ...